Representative immunostaining from cancer sample sections confirmed that the levels of KI-67, a cell proliferation marker, and CDC25B, the FOXM1 downstream target gene, were dramatically down-regulated (Fig. 5C). The gene discussed is CDC25B; the disease is cancer.